{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:16:36Z","timestamp":1783815396744,"version":"3.55.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2010,8,20]],"date-time":"2010-08-20T00:00:00Z","timestamp":1282262400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0012293","type":"journal-article","created":{"date-parts":[[2010,8,20]],"date-time":"2010-08-20T20:52:59Z","timestamp":1282337579000},"page":"e12293","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":80,"title":["Constitutively Nuclear FOXO3a Localization Predicts Poor Survival and Promotes Akt Phosphorylation in Breast Cancer"],"prefix":"10.1371","volume":"5","author":[{"given":"Jie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana R.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara J.","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San Yu","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina T.","family":"Karadedou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Millour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chi","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuen Nei","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sunters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin Y. K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric W.-F.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ui-Soon","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,8,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrc721","article-title":"Endocrine-responsive breast cancer and strategies for combating resistance.","volume":"2","author":"S Ali","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1185\/0300799019117015","article-title":"Pure antiestrogens and breast cancer.","volume":"17","author":"AE Elkak","year":"2001","journal-title":"Curr Med Res Opin"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10147-008-0818-7","article-title":"Current research topics in endocrine therapy for breast cancer.","volume":"13","author":"H Yamashita","year":"2008","journal-title":"Int J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3816\/CBC.2008.n.049","article-title":"Extended adjuvant endocrine therapy in breast cancer: current status and future directions.","volume":"8","author":"PE Goss","year":"2008","journal-title":"Clin Breast Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00001813-199711000-00002","article-title":"Acquired tamoxifen resistance in human breast cancer\u2014potential mechanisms and clinical implications.","volume":"8","author":"SR Johnston","year":"1997","journal-title":"Anticancer Drugs"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0960-0760(00)00193-X","article-title":"Molecular and pharmacological aspects of antiestrogen resistance.","volume":"76","author":"R Clarke","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0031-6997(24)01479-0","article-title":"Cellular and molecular pharmacology of antiestrogen action and resistance.","volume":"53","author":"R Clarke","year":"2001","journal-title":"Pharmacol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1373\/clinchem.2004.046227","article-title":"Predictive markers in breast and other cancers: a review.","volume":"51","author":"MJ Duffy","year":"2005","journal-title":"Clin Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2004.09.008","article-title":"Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?","volume":"31","author":"OC Freedman","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"9817","DOI":"10.1074\/jbc.M010840200","article-title":"Phosphatidylinositol 3-kinase\/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.","volume":"276","author":"RA Campbell","year":"2001","journal-title":"J Biol Chem"},{"key":"ref11","first-page":"2933","article-title":"Expression of constitutively active Akt-3 in MCF-7 breast cancer cells reverses the estrogen and tamoxifen responsivity of these cells in vivo.","volume":"9","author":"J Faridi","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/annonc\/mdg291","article-title":"Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity.","volume":"14","author":"LA DeGraffenried","year":"2003","journal-title":"Ann Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1677\/erc.1.00946","article-title":"Antiestrogen-resistant human breast cancer cells require activated protein kinase B\/Akt for growth.","volume":"12","author":"T Frogne","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrc2223","article-title":"The emerging roles of forkhead box (Fox) proteins in cancer.","volume":"7","author":"SS Myatt","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.","volume":"96","author":"A Brunet","year":"1999","journal-title":"Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0092-8674(04)00302-2","article-title":"IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.","volume":"117","author":"MC Hu","year":"2004","journal-title":"Cell"},{"key":"ref17","first-page":"197","article-title":"Expression and intracellular localization of FKHRL1 in mammary gland neoplasms.","volume":"58","author":"GS Jin","year":"2004","journal-title":"Acta Med Okayama"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1021\/cb600352f","article-title":"A small molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN).","volume":"1","author":"E Rosivatz","year":"2006","journal-title":"ACS Chem Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1182\/blood-2008-07-167023","article-title":"BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3.","volume":"113","author":"A Nordigarden","year":"2009","journal-title":"Blood"},{"key":"ref20","first-page":"81","article-title":"Endocrine therapy of human breast cancer cells: the role of secreted polypeptide growth factors.","volume":"1","author":"N Brunner","year":"1989","journal-title":"Cancer Cells"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1158\/1535-7163.MCT-07-0507","article-title":"The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cells.","volume":"6","author":"J Krol","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"49795","DOI":"10.1074\/jbc.M309523200","article-title":"FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines.","volume":"278","author":"A Sunters","year":"2003","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1128\/MCB.01265-07","article-title":"The forkhead transcription factor FOXO3a increases phosphoinositide-3 kinase\/Akt activity in drug-resistant leukemic cells through induction of PIK3CA expression.","volume":"28","author":"RC Hui","year":"2008","journal-title":"Mol Cell Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/1535-7163.MCT-07-0397","article-title":"Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells.","volume":"7","author":"RC Hui","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"ref25","first-page":"707","article-title":"Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells.","volume":"1","author":"AS Clark","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1158\/1535-7163.MCT-08-0398","article-title":"FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells.","volume":"7","author":"S Fernandez de Mattos","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1158\/0008-5472.CAN-05-1997","article-title":"Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt.","volume":"66","author":"A Sunters","year":"2006","journal-title":"Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1158\/1535-7163.MCT-08-0805","article-title":"Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer.","volume":"8","author":"UB McGovern","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1158\/1535-7163.MCT-08-0188","article-title":"Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.","volume":"7","author":"JM Kwok","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/1078-0432.CCR-08-0124","article-title":"A new fork for clinical application: targeting forkhead transcription factors in cancer.","volume":"15","author":"JY Yang","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0083-6729(05)71007-4","article-title":"Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer.","volume":"71","author":"RB Riggins","year":"2005","journal-title":"Vitam Horm"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1476-4598-4-33","article-title":"The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells.","volume":"4","author":"RB Riggins","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1128\/MCB.00077-09","article-title":"FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases.","volume":"29","author":"P Storz","year":"2009","journal-title":"Mol Cell Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0012293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T21:15:23Z","timestamp":1740431723000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0012293"}},"subtitle":[],"editor":[{"given":"Chad","family":"Creighton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,8,20]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,8,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0012293","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,20]]}}}